Study Evaluating Etanercept for the Treatment of Moderate to Severe Psoriasis

NCT00663052 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
273
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer